
Paul Hudson
Fortuna: 700 705 $ al 30/09/2026

Fortuna: 700 705 $ al 30/09/2026
El Sr. Paul Hudson es director general y consejero de Sanofi, presidente de Novartis Pharma KK y director general y consejero de Sanofi Clir SENC. Forma parte del Consejo de Administración de Sanofi y Sanofi Clir SENC. Anteriormente, el Sr. Hudson fue Director General de Novartis Pharmaceuticals Corp., Presidente de AstraZeneca US y Vicepresidente Ejecutivo de América del Norte de AstraZeneca Plc, Presidente de AstraZneca Farmacutica Spain SA, Presidente y Director de AstraZeneca KK, Miembro del Comité Ejecutivo de Novartis AG y Jefe de Marketing Global de Schering Plough Holdings France SAS. Se licenció en la Universidad Metropolitana de Manchester.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 19/10/2026 | 6.139 ( 0 % ) | 700 705 $ | 30/09/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| INSMED INCORPORATED | Director/Miembro de la Junta | 20/10/2026 |
Novartis Pharma KK
Novartis Pharma KK Pharmaceuticals: MajorHealth Technology Develops, imports, produces and markets pharmaceutical products | Presidente | - |
| Empresas | Cargo | Fin |
|---|---|---|
| SANOFI | Director Ejecutivo | 17/02/2026 |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Director Ejecutivo | 01/01/2019 |
| ASTRAZENECA PLC | Corporate Officer/Principal | 01/06/2016 |
Schering Plough Holdings France SAS
Schering Plough Holdings France SAS Pharmaceuticals: OtherHealth Technology Manufactures healthcare products and medicines | Ventas & Marketing | - |
Sanofi Clir SNC
Sanofi Clir SNC Medical DistributorsDistribution Services Wholesales pharmaceutical products | Director Ejecutivo | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 11 |
|---|---|
AstraZeneca PLC
AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Insmed, Inc.
Insmed, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases | Health Technology |
Sanofi
Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
Novartis AG
Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Health Technology |
Manchester Metropolitan University
Manchester Metropolitan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AstraZeneca KK
AstraZeneca KK Pharmaceuticals: MajorHealth Technology Develops, manufactures and sells medical drugs | Health Technology |
AstraZéneca Farmacéutica Spain SA
AstraZéneca Farmacéutica Spain SA Pharmaceuticals: MajorHealth Technology Produces pharmaceutical products | Health Technology |
Novartis Pharma KK
Novartis Pharma KK Pharmaceuticals: MajorHealth Technology Develops, imports, produces and markets pharmaceutical products | Health Technology |
Schering Plough Holdings France SAS
Schering Plough Holdings France SAS Pharmaceuticals: OtherHealth Technology Manufactures healthcare products and medicines | Health Technology |
Sanofi Clir SNC
Sanofi Clir SNC Medical DistributorsDistribution Services Wholesales pharmaceutical products | Distribution Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.